Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2008
05/22/2008WO2008059866A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents
05/22/2008WO2008059865A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents
05/22/2008WO2008059854A1 Piperidine derivatives or salts thereof
05/22/2008WO2008059800A1 Novel polyamine derivatives
05/22/2008WO2008059662A1 Retrovirus-infection inhibitor
05/22/2008WO2008059625A1 Utilization of the function of rare sugar as promoter for the migration of glucokinase from nucleus to cytoplasm
05/22/2008WO2008059541A1 Cosmetic product for the treatment of cicatricial tissues
05/22/2008WO2008059516A2 Process for purification of macrolides
05/22/2008WO2008059513A2 Compounds suitable as modulators of hdl
05/22/2008WO2008059502A2 Contact lens compositions
05/22/2008WO2008059501A2 Use of lipid conjugates in the treatment of diseases or disorders of the eye
05/22/2008WO2008059491A1 Methods of treating cancer using sirna molecules directed against cd24
05/22/2008WO2008059373A1 Imidazo [1, 2-a] pyrazine derivatives and their use as acid pump antagonists
05/22/2008WO2008059370A2 Substituted bicyclocarboxyamide compounds
05/22/2008WO2008059368A2 Fused 2-amino pyrimidine compounds and their use for the treatment of cancer
05/22/2008WO2008059367A1 Penem prodrugs
05/22/2008WO2008059339A2 Isoquinoline derivatives as vanilloid receptor modulators
05/22/2008WO2008059335A1 Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof
05/22/2008WO2008059267A1 Selective glycosidase inhibitors
05/22/2008WO2008059261A1 Clotrimazol for treating staphylococcal infections
05/22/2008WO2008059258A2 Imidazoles for treating multi-drug resistant bacterial infections
05/22/2008WO2008059245A1 Quiniclidine derivatives of (hetero) arylcycloheptanecarboxylic acid as muscarinic receptor antagonists
05/22/2008WO2008059239A1 Novel compounds 514
05/22/2008WO2008059238A1 Benzenesulfonamide compounds as edg-1 antagonists useful in the treatment of cancer
05/22/2008WO2008059224A1 Use of buprenorphine or n-alkylated derivatives thereof for wound healing
05/22/2008WO2008059223A2 Process for the synthesis of moxifloxacin hydrochloride
05/22/2008WO2008059214A1 Bisamlde derivatives and use thereof as fatty acid synthase inhibitors
05/22/2008WO2008059207A1 Cannabinoid receptor modulators
05/22/2008WO2008059197A2 Topical composition comprising an anti- inflammatory steroid and a non-steroidal anti -inflammatory drug
05/22/2008WO2008059190A1 Treatment of excess sebum production
05/22/2008WO2008059141A1 Aminobenzocycloheptene derivatives, methods for preparing the same and uses thereof in therapy
05/22/2008WO2008059130A1 Thionucleosides and pharmaceutical applications
05/22/2008WO2008059128A1 Phenylic derivatives and use thereof as drugs
05/22/2008WO2008059068A2 Carbonyl-substituted titanocenes
05/22/2008WO2008059060A1 Liquid pharmaceutical compositions comprising a bisphosphonate compound
05/22/2008WO2008059059A1 Pharmaceutical compositions comprising a bisphosphonate compound
05/22/2008WO2008059052A1 Improved methods of using phosphoantigen for the treatment of cancer
05/22/2008WO2008059046A1 Macrocyclic inhibitors of hepatitis c virus
05/22/2008WO2008059029A2 New polymorphs of ethyl 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionate
05/22/2008WO2008059026A1 Novel 2-(2-hydroxyphenyl)benzimidazoles useful for treating obesity and diabetes
05/22/2008WO2008059025A1 Novel 2-(2-hydroxyphenyl) benzothiadiazines useful for treating obesity and diabetes
05/22/2008WO2008059024A1 2- ( 2 -hydroxyphenyl) -quinazolin-4-ones useful for treating obesity and diabetes
05/22/2008WO2008059023A1 New haloalkylsulfone substituted compounds useful for treating obesity and diabetes
05/22/2008WO2008059014A2 Antituberculosis agents with alkylidene or alkyl side chain
05/22/2008WO2008059003A1 Novel compounds
05/22/2008WO2008058995A2 Use of cytohesin inhibitors for chemically inducing longevity
05/22/2008WO2008058993A2 Use of alpha ketogluaric acid for the treatment of infection with h. pylori
05/22/2008WO2008058992A1 New crystalline form of entacapone and process for its preparation
05/22/2008WO2008058990A1 7,7-disubstituted pyrano-[2,3-c]-imidazo-[1,2-a]-pyridine derivatives and their use as gastric acid secretion inhibitors
05/22/2008WO2008058988A1 Pyrrolo[1,2-a]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents
05/22/2008WO2008058968A1 Crystalline form of tiotropium bromide and urea
05/22/2008WO2008058967A1 Organic compounds
05/22/2008WO2008058961A1 Heterocyclic derivatives as cetp inhibitors
05/22/2008WO2008058897A2 Diphyllin and other lignans as a medicament for v-atpase mediated disease
05/22/2008WO2008058867A2 Substituted 4-imidazoles
05/22/2008WO2008058767A1 Progesterone receptor antagonists
05/22/2008WO2008058766A1 Ep2 and ep4 agonists as agents for the treatment of influenza a viral infection
05/22/2008WO2008058728A1 Compositions and methods for immunotherapy
05/22/2008WO2008058644A1 Polymorph ii of 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide
05/22/2008WO2008058641A1 Imidazo[2, 1-b]thiazoles and their use as pharmaceuticals
05/22/2008WO2008058631A1 Novel 1,4-benzothiepin-1,1-dioxide derivatives with improved properties, method for producing the same, drugs containing said compounds and use thereof
05/22/2008WO2008058630A1 Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with fluorine, method for producing the same, drugs containing said compounds and use thereof
05/22/2008WO2008058629A1 Novel 1,4-benzothiepin-1,1 -dioxide derivatives which are substituted with cyclohexyl groups, method for producing the same, drugs containing said compounds and use thereof
05/22/2008WO2008058628A1 Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
05/22/2008WO2008058547A2 Alpha-lactalbumin composition
05/22/2008WO2008058537A1 Novel 2-amino-pyridine derivatives and their use as potassium channel modulators
05/22/2008WO2008058536A1 Novel 4-amino-pyridine derivatives and their use as potassium channel modulators
05/22/2008WO2008058514A1 Preparations comprising boswellic acids for inhibiting the synthesis of prostaglandin e2
05/22/2008WO2008058451A2 Ultrasound microbubble mediated genes delivery system
05/22/2008WO2008058449A1 Pyrroline-2-one derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof
05/22/2008WO2008058448A1 Pyrroline derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof
05/22/2008WO2008058438A1 The use of ferric citrate in the manufacture of medicaments for treating blood vessel calcification
05/22/2008WO2008058402A1 Compounds and methods for treating protein folding disorders
05/22/2008WO2008058394A1 Polymorphisms predictive of anthracycline-induced cardiotoxicity
05/22/2008WO2008058393A1 Thiophene analogues for the treatment or prevention of flavivirus infections
05/22/2008WO2008058387A1 Renin inhibitors
05/22/2008WO2008058383A1 Acat inhibitors and their use in the prevention or treatment of fibrosis
05/22/2008WO2008058366A1 Oil-in-water emulsions, methods of use thereof, methods of preparation thereof and kits thereof
05/22/2008WO2008058358A2 Descriptive report of the patent of invention of the medicament 'rosuvastatin + metformin' in combined form for cardiovascular diseases.
05/22/2008WO2008058357A2 Descriptive report of patent of invention of the medicament candesartana + metformin in combined form for cardiovascular diseases
05/22/2008WO2008058355A2 Descriptive report of patent of invention of the medicament 'atorvastatin + metformin' in combined form for cardiovascular diseases
05/22/2008WO2008058354A2 Descriptive report of the 'patent of invention of the medicament 'ramipril + metformin in combined form for cardiovascular diseases
05/22/2008WO2008058353A2 Descriptive report of the patent of invention of the medicament 'telmisartana + metformin' in combined form for cardiovascular diseases
05/22/2008WO2008058342A1 Compounds, compositions and methods for controlling invertebrate pests
05/22/2008WO2008058341A1 Inhibitors of kinase activity
05/22/2008WO2008043087A3 Bicyclic nitrogen-containing heterocyclic compounds for use as stearoyl coa desaturase inhibitors
05/22/2008WO2008042968A3 Di-fluoro containing compounds as cysteine protease inhibitors
05/22/2008WO2008042282A3 Imidazole-4, 5-dicarboxamide derivatives as jak-2 modulators
05/22/2008WO2008039898A3 Methods for the treatment of a traumatic central nervous system injury
05/22/2008WO2008039751A3 2-methylene-(20s,25s)-19,27-dinor-(22e)-vitamin d analogs
05/22/2008WO2008038304A3 Therapeutical formulation comprising an alpha-glucosidase inhibitor and a nitric oxide scavenger.
05/22/2008WO2008037881A3 Derivatives of pyrrolizine, indolizine and quinolizine, preparation thereof and therapeutic use thereof
05/22/2008WO2008037502A3 Olanzapine pharmaceutical composition with anhydrous lactose
05/22/2008WO2008036420A3 9-(heteroaryl)-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents
05/22/2008WO2008035001A3 Composition for the treatment of amyotrophic lateral sclerosis
05/22/2008WO2008033024A3 Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances
05/22/2008WO2008032191A3 Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators
05/22/2008WO2008031835A3 Method of treating autoimmune diseases using vegf-pathway inhibitors
05/22/2008WO2008031113A8 Improved method for inhibition of neovascularization
05/22/2008WO2008030638A3 Use of dmso and botulinum toxin therapy for urinary incontinence and related disorders
1 ... 3251 3252 3253 3254 3255 3256 3257 3258 3259 3260 3261 3262 3263 3264 3265 3266 3267 3268 3269 3270 3271 ... 7860